As a 16-year CLL patient himself, Brad brings a personal perspective as Dr. Rogers explains what fixed duration treatment means, which drug combinations are currently approved, and what the ramp-up process looks like, including why close monitoring is required in the early weeks. They discuss how treatment length is determined, what ongoing monitoring looks like, and how side effects typically resolve once treatment ends. Dr. Rogers also breaks down how factors like disease genetics, other health conditions, lifestyle, and personal preference all play a role in deciding whether fixed duration or continuous therapy is the right fit for each patient.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Brad Adams is joined by Paul J. Hampel, MD, a hematologist-oncologist at Mayo Clinic in Rochester, for a conversation about fixed duration versus continuous treatment for chronic lymphocytic leukemia (CLL), including benefits, side effects, monitoring, and how to choose the best option based on your lifestyle and disease features.

In this episode of the Patient Power podcast, Unraveling Cancer, patient host Michele Nadeem-Baker is joined by Thomas Kipps, MD, PhD, UC San Diego, for a conversation about the latest immune-based advances in chronic lymphocytic leukemia (CLL), including targeted therapies, CAR T-cell treatment, vaccines, and infection prevention. Learn how new research is improving outcomes and bringing hope for a future cure.